Publication | Closed Access

Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma

Tumor BiologyMalignant DiseaseOncogenic AgentMedicineEpigenetic Drug TargetMolecular BiologyCancer GenomicsLysine-specific Demethylase 1Cancer GeneticsCancer BiologyCell BiologyEpigeneticsCancer Research